Organon & Co. Stock Analysis & AI Score
Organon & Co. (OGN) has an ST Score of 45.9 (C+), driven by its Valuation (B+) and held back by its Growth (D-). Analysts rate it Hold with a $13.00 price target (-5.2% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Organon & Co. (OGN) has an ST Score of 45.9 (C+), driven by its Valuation (B+) and held back by its Growth (D-). Analysts rate it Hold with a $13.00 price target (-5.2% downside).
- Strongest
- ValuationB+
- Weakest
- GrowthD-
All factor grades
- ValuationB+
- MomentumB
- ForecastC+
- ProfitabilityC-
- Financial StrengthC-
- GrowthD-
- Piotroski6/9
Contact
OGN stock: frequently asked questions
What is OGN's ST Score?
Organon & Co. (OGN) has an ST Score of 45.9 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is OGN a buy, hold, or sell?
Analysts rate OGN a Hold, with a price target of $13.00 (-5.2% vs the current price). Our ST Score grades it C+ (45.9/100). The ST Score is a data-driven signal, not a recommendation.
What are OGN's factor grades?
Valuation B+, Profitability C-, Financial Strength C-, Momentum B, Growth D-, Forecast C+.
What is OGN's valuation grade?
Organon & Co. (OGN) earns a valuation grade of B+, measured against Drug Manufacturers - General peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is OGN's growth grade?
Organon & Co. (OGN) earns a growth grade of D-, measured against Drug Manufacturers - General peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is OGN's profitability grade?
Organon & Co. (OGN) earns a profitability grade of C-, measured against Drug Manufacturers - General peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is OGN's financial strength grade?
Organon & Co. (OGN) earns a financial strength grade of C-, measured against Drug Manufacturers - General peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for OGN?
The average analyst price target for Organon & Co. (OGN) is $13.00 from 9 analysts, which is -5.2% versus the recent price of $13.72.
What is OGN's Piotroski score?
Organon & Co. (OGN) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.